Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Teva Puerto Rico LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

Phase 2

Completed

Conditions: Vulvovaginal Atrophy
Menopause
Dyspareunia

Interventions: Drug: Estradiol Vaginal Capsule (EVC)
Drug: Placebo

First Posted Date: 2016-02-02

Last Posted Date: 2017-08-23

Lead Sponsor: Warner Chilcott

Target Recruit Count: 203

Registration Number: NCT02670785

Locations: 🇺🇸
Visions Clinical Research-Tucson, Tucson, Arizona, United States
🇺🇸
Genesis Center for Clinical Research, San Diego, California, United States
🇺🇸
Coastal Connecticut Research, LLC, New London, Connecticut, United States

and more 14 locations

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Phase 2

Completed

Conditions: Benign Prostatic Hyperplasia

Interventions: Drug: WC3055
Other: Placebo

First Posted Date: 2013-09-11

Last Posted Date: 2015-06-29

Lead Sponsor: Warner Chilcott

Target Recruit Count: 796

Registration Number: NCT01939184

Locations: 🇺🇸
Warner Chilcott Investigational Study Site, Wauwatosa, Wisconsin, United States
🇺🇸
Warner Chilcottt Investigational Study Site, Clearwater, Florida, United States

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

Phase 3

Completed

Conditions: Vulvovaginal Atrophy

Interventions: Drug: WC3011 Estradiol Vaginal Cream
Drug: Vehicle

First Posted Date: 2013-05-03

Last Posted Date: 2022-05-09

Lead Sponsor: Warner Chilcott

Target Recruit Count: 550

Registration Number: NCT01845649

Locations: 🇺🇸
Warner Chilcott Investigational Study Site, Spokane, Washington, United States

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

Phase 3

Completed

Conditions: Vulvovaginal Atrophy

Interventions: Drug: Vehicle
Drug: WC3011 Estradiol Vaginal Cream

First Posted Date: 2013-03-21

Last Posted Date: 2022-05-09

Lead Sponsor: Warner Chilcott

Target Recruit Count: 576

Registration Number: NCT01816139

Locations: 🇺🇸
Warner Chilcott Investigational Study Site, Spokane, Washington, United States

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Phase 2

Terminated

Conditions: Erectile Dysfunction

Interventions: Drug: WC3036-11F/Alprostadil in Vehicle 2.5%
Drug: WC3036-12F/Alprostadil in Vehicle 0.5%
Drug: WC3036-13P/Vehicle Only 0.5%

First Posted Date: 2013-03-13

Last Posted Date: 2014-08-12

Lead Sponsor: Warner Chilcott

Target Recruit Count: 16

Registration Number: NCT01810575

Locations: 🇺🇸
Warner Chilcott Investigational Study Site, Purchase, New York, United States

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Phase 3

Completed

Conditions: Vulvovaginal Atrophy

Interventions: Drug: WC3011 Estradiol Vaginal Cream

First Posted Date: 2011-10-20

Last Posted Date: 2022-05-09

Lead Sponsor: Warner Chilcott

Target Recruit Count: 309

Registration Number: NCT01455597

Locations: 🇺🇸
Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States
🇺🇸
Warner Chilcott Investigational Site, Mobile, Alabama, United States
🇺🇸
Women's Health Research, Phoenix, Arizona, United States

and more 59 locations

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women

Phase 3

Completed

Conditions: Postmenopausal Vulvovaginal Atrophy

Interventions: Drug: WC3011 Estradiol Vaginal Cream
Drug: Vehicle

First Posted Date: 2011-07-22

Last Posted Date: 2022-05-09

Lead Sponsor: Warner Chilcott

Target Recruit Count: 722

Registration Number: NCT01400776

Locations: 🇺🇸
Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States
🇺🇸
Mobile OB-GYN, PC, Mobile, Alabama, United States
🇺🇸
Women's Health Research, Phoenix, Arizona, United States

and more 64 locations

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Phase 3

Completed

Conditions: Postmenopausal Women With Osteoporosis

Interventions: Drug: Placebo/Risedronate
Drug: Risedronate

First Posted Date: 2010-11-29

Last Posted Date: 2011-11-02

Lead Sponsor: Warner Chilcott

Target Recruit Count: 61

Registration Number: NCT01249261

Locations: 🇸🇪
Investigational Site, Goteborg, Sweden

Effect of Udenafil on Spermatogenesis

Phase 1

Completed

Conditions: Spermatogenesis
Erectile Dysfunction

Interventions: Drug: Placebo
Drug: Udenafil

First Posted Date: 2010-10-29

Last Posted Date: 2011-11-30

Lead Sponsor: Warner Chilcott

Target Recruit Count: 239

Registration Number: NCT01230541

Locations: 🇺🇸
Warner Chilcott Investigational Site, Spokane, Washington, United States

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Phase 3

Completed

Conditions: Urogential Chlamydia Trachomatis Infection

Interventions: Drug: Doxycyline Hyclate tablet
Drug: Vibramycin (doxycyline hyclate) capsule

First Posted Date: 2010-04-30

Last Posted Date: 2012-01-27

Lead Sponsor: Warner Chilcott

Target Recruit Count: 495

Registration Number: NCT01113931

Locations: 🇺🇸
Research Site, Tacoma, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy